Triple-negative breast cancer (TNBC) is an aggressive form of the disease that accounts for 15% of all breast cancer cases.

Racial and ethnic disparities were identified in immunotherapy receipt for Black patients with metastatic triple-negative ...

It was a Novartis ad with comedian Wanda Sykes, who, alongside MCU actress Hailee Steinfield, spoke about the importance of ...

Krista Gerlich is known for many things: being the head coach for the Texas Tech women’s basketball team, winning a national ...

Olema Pharmaceuticals is developing palazestrant, an oral SERD in phase 3 trials for ER+/HER2- metastatic breast cancer. Read why OLMA stock is a Hold.

Discover the most effective methods for early breast cancer detection, combining modern breast awareness techniques with ...

Chinese Society of Clinical Oncology Breast Cancer (CSCO BC) guidelines mark a significant milestone in breast cancer treatment, seamlessly integrating cutting-edge international research with Chinese ...

The UK's National Health Service (NHS) has launched the world's largest prospective trial of using artificial intelligence (AI) to assess routine mammogram screenings. Nearly 700 000 women who have ...

One patient with TNBC describes the challenges she faced trying to de-escalate a grueling treatment regimen despite warnings ...

Discover why male breast cancer cases are rising, learn essential warning signs most men miss, and understand new treatment options that could save lives.

Dr. Debu Tripathy discusses the FDA approval of Enhertu in unresectable or metastatic hormone receptor HR+, HER2-low or ...

Scientists have developed new light-sensitive chemicals that can radically improve the treatment of aggressive cancers with ...